Global Neurosurgery Drug Production, Demand and Key Producers, 2022-2028
Neurosurgery is the surgery of the nervous system. Most of the time people think that neurosurgery is nothing but the surgery of the brain but looking deeply it is much more than that. Neurosurgery is the medical specialty that is concerned with the diagnosis of an injury or the disease that is concerned with the brain. Depending upon the patients and injury or disease doctor may choose to go for non-surgical procedures as well. There are several drugs present in the market which helps in getting relief from post neurosurgical seizures and pain. Which requires the doctor’s approval.
This report studies the global Neurosurgery Drug production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Neurosurgery Drug, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Neurosurgery Drug that contribute to its increasing demand across many markets.
The global Neurosurgery Drug market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Neurosurgery Drug total production and demand, 2017-2028, (K Units)
Global Neurosurgery Drug total production value, 2017-2028, (USD Million)
Global Neurosurgery Drug production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Neurosurgery Drug consumption by region & country, CAGR, 2017-2028 & (K Units)
U.S. VS China: Neurosurgery Drug domestic production, consumption, key domestic manufacturers and share
Global Neurosurgery Drug production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (K Units)
Global Neurosurgery Drug production by Type, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Neurosurgery Drug production by Application production, value, CAGR, 2017-2028, (USD Million) & (K Units)
This reports profiles key players in the global Neurosurgery Drug market based on the following parameters – headquarters, production locations, products portfolio, Neurosurgery Drug revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Neurosurgery Drug market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Neurosurgery Drug Market, By Region:
1. How big is the global Neurosurgery Drug market?
2. What is the demand of the global Neurosurgery Drug market?
3. What is the year over year growth of the global Neurosurgery Drug market?
4. What is the production and production value of the global Neurosurgery Drug market?
5. Who are the key producers in the global Neurosurgery Drug market?
6. What are the growth factors driving the market demand?
This report studies the global Neurosurgery Drug production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Neurosurgery Drug, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Neurosurgery Drug that contribute to its increasing demand across many markets.
The global Neurosurgery Drug market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Neurosurgery Drug total production and demand, 2017-2028, (K Units)
Global Neurosurgery Drug total production value, 2017-2028, (USD Million)
Global Neurosurgery Drug production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Neurosurgery Drug consumption by region & country, CAGR, 2017-2028 & (K Units)
U.S. VS China: Neurosurgery Drug domestic production, consumption, key domestic manufacturers and share
Global Neurosurgery Drug production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (K Units)
Global Neurosurgery Drug production by Type, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Neurosurgery Drug production by Application production, value, CAGR, 2017-2028, (USD Million) & (K Units)
This reports profiles key players in the global Neurosurgery Drug market based on the following parameters – headquarters, production locations, products portfolio, Neurosurgery Drug revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Neurosurgery Drug market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Neurosurgery Drug Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Tablets
- Solution
- Capsules
- Others
- Hospital
- Clinic
- Others
- Pfizer
- AstraZeneca
- Biogen
- Jhonson & Jhonson
- ABBVIE
- Takeda Pharmaceuticals
- UCB
- IPSEN
- Standigm
- BlueStar Genomic
- Tonix Pharmaceuticals
- BlackThorn Therapeutics
- Quentrix
- Wren Pharmaceuticals
1. How big is the global Neurosurgery Drug market?
2. What is the demand of the global Neurosurgery Drug market?
3. What is the year over year growth of the global Neurosurgery Drug market?
4. What is the production and production value of the global Neurosurgery Drug market?
5. Who are the key producers in the global Neurosurgery Drug market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Neurosurgery Drug Introduction
1.2 World Neurosurgery Drug Supply & Forecast
1.2.1 World Neurosurgery Drug Production Value (2017 & 2021 & 2028)
1.2.2 World Neurosurgery Drug Production (2017-2028)
1.2.3 World Neurosurgery Drug Pricing Trends (2017-2028)
1.3 World Neurosurgery Drug Production by Region
1.3.1 World Neurosurgery Drug Production Value by Region (2017-2028)
1.3.2 World Neurosurgery Drug Production by Region (2017-2028)
1.3.3 World Neurosurgery Drug Average Price by Region (2017-2028)
1.3.4 North America Neurosurgery Drug Production (2017-2028)
1.3.5 Europe Neurosurgery Drug Production (2017-2028)
1.3.6 China Neurosurgery Drug Production (2017-2028)
1.3.7 Japan Neurosurgery Drug Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Neurosurgery Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Neurosurgery Drug Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Neurosurgery Drug Demand (2017-2028)
2.2 World Neurosurgery Drug Consumption by Region
2.2.1 World Neurosurgery Drug Consumption by Region (2017-2022)
2.2.2 World Neurosurgery Drug Consumption Forecast by Region (2023-2028)
2.3 United States Neurosurgery Drug Consumption (2017-2028)
2.4 China Neurosurgery Drug Consumption (2017-2028)
2.5 Europe Neurosurgery Drug Consumption (2017-2028)
2.6 Japan Neurosurgery Drug Consumption (2017-2028)
2.7 South Korea Neurosurgery Drug Consumption (2017-2028)
2.8 ASEAN Neurosurgery Drug Consumption (2017-2028)
2.9 India Neurosurgery Drug Consumption (2017-2028)
3 WORLD NEUROSURGERY DRUG MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Neurosurgery Drug Production Value by Manufacturer (2017-2022)
3.2 World Neurosurgery Drug Production by Manufacturer (2017-2022)
3.3 World Neurosurgery Drug Average Price by Manufacturer (2017-2022)
3.4 Neurosurgery Drug Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Neurosurgery Drug Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Neurosurgery Drug in 2021
3.5.3 Global Concentration Ratios (CR8) for Neurosurgery Drug in 2021
3.6 Neurosurgery Drug Market: Overall Company Footprint Analysis
3.6.1 Neurosurgery Drug Market: Region Footprint
3.6.2 Neurosurgery Drug Market: Company Product Type Footprint
3.6.3 Neurosurgery Drug Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Neurosurgery Drug Production Value Comparison
4.1.1 United States VS China: Neurosurgery Drug Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: Neurosurgery Drug Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: Neurosurgery Drug Production Comparison
4.2.1 United States VS China: Neurosurgery Drug Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: Neurosurgery Drug Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: Neurosurgery Drug Consumption Comparison
4.3.1 United States VS China: Neurosurgery Drug Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: Neurosurgery Drug Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States Neurosurgery Drug Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of Neurosurgery Drug in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States Neurosurgery Drug Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States Neurosurgery Drug Production by Domestic Manufacturer, (2017-2022)
4.5 China Neurosurgery Drug Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of Neurosurgery Drug in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China Neurosurgery Drug Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China Neurosurgery Drug Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World Neurosurgery Drug Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of Neurosurgery Drug in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World Neurosurgery Drug Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World Neurosurgery Drug Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World Neurosurgery Drug Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 Tablets
5.2.2 Solution
5.2.3 Capsules
5.2.4 Others
5.3 Market Segment by Type
5.3.1 World Neurosurgery Drug Production by Type (2017-2028)
5.3.2 World Neurosurgery Drug Production Value by Type (2017-2028)
5.3.3 World Neurosurgery Drug Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Neurosurgery Drug Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Neurosurgery Drug Production by Application (2017-2028)
6.3.2 World Neurosurgery Drug Production Value by Application (2017-2028)
6.3.3 World Neurosurgery Drug Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 Pfizer
7.1.1 Pfizer Details
7.1.2 Pfizer Major Business
7.1.3 Pfizer Neurosurgery Drug Product and Services
7.1.4 Pfizer Neurosurgery Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 Pfizer Recent Developments/Updates
7.1.6 Pfizer Competitive Strengths & Weaknesses
7.2 AstraZeneca
7.2.1 AstraZeneca Details
7.2.2 AstraZeneca Major Business
7.2.3 AstraZeneca Neurosurgery Drug Product and Services
7.2.4 AstraZeneca Neurosurgery Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 AstraZeneca Recent Developments/Updates
7.2.6 AstraZeneca Competitive Strengths & Weaknesses
7.3 Biogen
7.3.1 Biogen Details
7.3.2 Biogen Major Business
7.3.3 Biogen Neurosurgery Drug Product and Services
7.3.4 Biogen Neurosurgery Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 Biogen Recent Developments/Updates
7.3.6 Biogen Competitive Strengths & Weaknesses
7.4 Jhonson & Jhonson
7.4.1 Jhonson & Jhonson Details
7.4.2 Jhonson & Jhonson Major Business
7.4.3 Jhonson & Jhonson Neurosurgery Drug Product and Services
7.4.4 Jhonson & Jhonson Neurosurgery Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 Jhonson & Jhonson Recent Developments/Updates
7.4.6 Jhonson & Jhonson Competitive Strengths & Weaknesses
7.5 ABBVIE
7.5.1 ABBVIE Details
7.5.2 ABBVIE Major Business
7.5.3 ABBVIE Neurosurgery Drug Product and Services
7.5.4 ABBVIE Neurosurgery Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 ABBVIE Recent Developments/Updates
7.5.6 ABBVIE Competitive Strengths & Weaknesses
7.6 Takeda Pharmaceuticals
7.6.1 Takeda Pharmaceuticals Details
7.6.2 Takeda Pharmaceuticals Major Business
7.6.3 Takeda Pharmaceuticals Neurosurgery Drug Product and Services
7.6.4 Takeda Pharmaceuticals Neurosurgery Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 Takeda Pharmaceuticals Recent Developments/Updates
7.6.6 Takeda Pharmaceuticals Competitive Strengths & Weaknesses
7.7 UCB
7.7.1 UCB Details
7.7.2 UCB Major Business
7.7.3 UCB Neurosurgery Drug Product and Services
7.7.4 UCB Neurosurgery Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.7.5 UCB Recent Developments/Updates
7.7.6 UCB Competitive Strengths & Weaknesses
7.8 IPSEN
7.8.1 IPSEN Details
7.8.2 IPSEN Major Business
7.8.3 IPSEN Neurosurgery Drug Product and Services
7.8.4 IPSEN Neurosurgery Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.8.5 IPSEN Recent Developments/Updates
7.8.6 IPSEN Competitive Strengths & Weaknesses
7.9 Standigm
7.9.1 Standigm Details
7.9.2 Standigm Major Business
7.9.3 Standigm Neurosurgery Drug Product and Services
7.9.4 Standigm Neurosurgery Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.9.5 Standigm Recent Developments/Updates
7.9.6 Standigm Competitive Strengths & Weaknesses
7.10 BlueStar Genomic
7.10.1 BlueStar Genomic Details
7.10.2 BlueStar Genomic Major Business
7.10.3 BlueStar Genomic Neurosurgery Drug Product and Services
7.10.4 BlueStar Genomic Neurosurgery Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.10.5 BlueStar Genomic Recent Developments/Updates
7.10.6 BlueStar Genomic Competitive Strengths & Weaknesses
7.11 Tonix Pharmaceuticals
7.11.1 Tonix Pharmaceuticals Details
7.11.2 Tonix Pharmaceuticals Major Business
7.11.3 Tonix Pharmaceuticals Neurosurgery Drug Product and Services
7.11.4 Tonix Pharmaceuticals Neurosurgery Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.11.5 Tonix Pharmaceuticals Recent Developments/Updates
7.11.6 Tonix Pharmaceuticals Competitive Strengths & Weaknesses
7.12 BlackThorn Therapeutics
7.12.1 BlackThorn Therapeutics Details
7.12.2 BlackThorn Therapeutics Major Business
7.12.3 BlackThorn Therapeutics Neurosurgery Drug Product and Services
7.12.4 BlackThorn Therapeutics Neurosurgery Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.12.5 BlackThorn Therapeutics Recent Developments/Updates
7.12.6 BlackThorn Therapeutics Competitive Strengths & Weaknesses
7.13 Quentrix
7.13.1 Quentrix Details
7.13.2 Quentrix Major Business
7.13.3 Quentrix Neurosurgery Drug Product and Services
7.13.4 Quentrix Neurosurgery Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.13.5 Quentrix Recent Developments/Updates
7.13.6 Quentrix Competitive Strengths & Weaknesses
7.14 Wren Pharmaceuticals
7.14.1 Wren Pharmaceuticals Details
7.14.2 Wren Pharmaceuticals Major Business
7.14.3 Wren Pharmaceuticals Neurosurgery Drug Product and Services
7.14.4 Wren Pharmaceuticals Neurosurgery Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.14.5 Wren Pharmaceuticals Recent Developments/Updates
7.14.6 Wren Pharmaceuticals Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of Neurosurgery Drug and Key Manufacturers
8.2 Neurosurgery Drug Manufacturing Costs
8.3 Neurosurgery Drug Production Process
8.4 Neurosurgery Drug Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for Neurosurgery Drug Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Neurosurgery Drug Typical Distributors
9.3 Neurosurgery Drug Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
1.1 Neurosurgery Drug Introduction
1.2 World Neurosurgery Drug Supply & Forecast
1.2.1 World Neurosurgery Drug Production Value (2017 & 2021 & 2028)
1.2.2 World Neurosurgery Drug Production (2017-2028)
1.2.3 World Neurosurgery Drug Pricing Trends (2017-2028)
1.3 World Neurosurgery Drug Production by Region
1.3.1 World Neurosurgery Drug Production Value by Region (2017-2028)
1.3.2 World Neurosurgery Drug Production by Region (2017-2028)
1.3.3 World Neurosurgery Drug Average Price by Region (2017-2028)
1.3.4 North America Neurosurgery Drug Production (2017-2028)
1.3.5 Europe Neurosurgery Drug Production (2017-2028)
1.3.6 China Neurosurgery Drug Production (2017-2028)
1.3.7 Japan Neurosurgery Drug Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Neurosurgery Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Neurosurgery Drug Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Neurosurgery Drug Demand (2017-2028)
2.2 World Neurosurgery Drug Consumption by Region
2.2.1 World Neurosurgery Drug Consumption by Region (2017-2022)
2.2.2 World Neurosurgery Drug Consumption Forecast by Region (2023-2028)
2.3 United States Neurosurgery Drug Consumption (2017-2028)
2.4 China Neurosurgery Drug Consumption (2017-2028)
2.5 Europe Neurosurgery Drug Consumption (2017-2028)
2.6 Japan Neurosurgery Drug Consumption (2017-2028)
2.7 South Korea Neurosurgery Drug Consumption (2017-2028)
2.8 ASEAN Neurosurgery Drug Consumption (2017-2028)
2.9 India Neurosurgery Drug Consumption (2017-2028)
3 WORLD NEUROSURGERY DRUG MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Neurosurgery Drug Production Value by Manufacturer (2017-2022)
3.2 World Neurosurgery Drug Production by Manufacturer (2017-2022)
3.3 World Neurosurgery Drug Average Price by Manufacturer (2017-2022)
3.4 Neurosurgery Drug Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Neurosurgery Drug Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Neurosurgery Drug in 2021
3.5.3 Global Concentration Ratios (CR8) for Neurosurgery Drug in 2021
3.6 Neurosurgery Drug Market: Overall Company Footprint Analysis
3.6.1 Neurosurgery Drug Market: Region Footprint
3.6.2 Neurosurgery Drug Market: Company Product Type Footprint
3.6.3 Neurosurgery Drug Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Neurosurgery Drug Production Value Comparison
4.1.1 United States VS China: Neurosurgery Drug Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: Neurosurgery Drug Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: Neurosurgery Drug Production Comparison
4.2.1 United States VS China: Neurosurgery Drug Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: Neurosurgery Drug Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: Neurosurgery Drug Consumption Comparison
4.3.1 United States VS China: Neurosurgery Drug Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: Neurosurgery Drug Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States Neurosurgery Drug Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of Neurosurgery Drug in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States Neurosurgery Drug Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States Neurosurgery Drug Production by Domestic Manufacturer, (2017-2022)
4.5 China Neurosurgery Drug Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of Neurosurgery Drug in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China Neurosurgery Drug Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China Neurosurgery Drug Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World Neurosurgery Drug Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of Neurosurgery Drug in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World Neurosurgery Drug Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World Neurosurgery Drug Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World Neurosurgery Drug Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 Tablets
5.2.2 Solution
5.2.3 Capsules
5.2.4 Others
5.3 Market Segment by Type
5.3.1 World Neurosurgery Drug Production by Type (2017-2028)
5.3.2 World Neurosurgery Drug Production Value by Type (2017-2028)
5.3.3 World Neurosurgery Drug Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Neurosurgery Drug Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Neurosurgery Drug Production by Application (2017-2028)
6.3.2 World Neurosurgery Drug Production Value by Application (2017-2028)
6.3.3 World Neurosurgery Drug Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 Pfizer
7.1.1 Pfizer Details
7.1.2 Pfizer Major Business
7.1.3 Pfizer Neurosurgery Drug Product and Services
7.1.4 Pfizer Neurosurgery Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 Pfizer Recent Developments/Updates
7.1.6 Pfizer Competitive Strengths & Weaknesses
7.2 AstraZeneca
7.2.1 AstraZeneca Details
7.2.2 AstraZeneca Major Business
7.2.3 AstraZeneca Neurosurgery Drug Product and Services
7.2.4 AstraZeneca Neurosurgery Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 AstraZeneca Recent Developments/Updates
7.2.6 AstraZeneca Competitive Strengths & Weaknesses
7.3 Biogen
7.3.1 Biogen Details
7.3.2 Biogen Major Business
7.3.3 Biogen Neurosurgery Drug Product and Services
7.3.4 Biogen Neurosurgery Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 Biogen Recent Developments/Updates
7.3.6 Biogen Competitive Strengths & Weaknesses
7.4 Jhonson & Jhonson
7.4.1 Jhonson & Jhonson Details
7.4.2 Jhonson & Jhonson Major Business
7.4.3 Jhonson & Jhonson Neurosurgery Drug Product and Services
7.4.4 Jhonson & Jhonson Neurosurgery Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 Jhonson & Jhonson Recent Developments/Updates
7.4.6 Jhonson & Jhonson Competitive Strengths & Weaknesses
7.5 ABBVIE
7.5.1 ABBVIE Details
7.5.2 ABBVIE Major Business
7.5.3 ABBVIE Neurosurgery Drug Product and Services
7.5.4 ABBVIE Neurosurgery Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 ABBVIE Recent Developments/Updates
7.5.6 ABBVIE Competitive Strengths & Weaknesses
7.6 Takeda Pharmaceuticals
7.6.1 Takeda Pharmaceuticals Details
7.6.2 Takeda Pharmaceuticals Major Business
7.6.3 Takeda Pharmaceuticals Neurosurgery Drug Product and Services
7.6.4 Takeda Pharmaceuticals Neurosurgery Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 Takeda Pharmaceuticals Recent Developments/Updates
7.6.6 Takeda Pharmaceuticals Competitive Strengths & Weaknesses
7.7 UCB
7.7.1 UCB Details
7.7.2 UCB Major Business
7.7.3 UCB Neurosurgery Drug Product and Services
7.7.4 UCB Neurosurgery Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.7.5 UCB Recent Developments/Updates
7.7.6 UCB Competitive Strengths & Weaknesses
7.8 IPSEN
7.8.1 IPSEN Details
7.8.2 IPSEN Major Business
7.8.3 IPSEN Neurosurgery Drug Product and Services
7.8.4 IPSEN Neurosurgery Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.8.5 IPSEN Recent Developments/Updates
7.8.6 IPSEN Competitive Strengths & Weaknesses
7.9 Standigm
7.9.1 Standigm Details
7.9.2 Standigm Major Business
7.9.3 Standigm Neurosurgery Drug Product and Services
7.9.4 Standigm Neurosurgery Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.9.5 Standigm Recent Developments/Updates
7.9.6 Standigm Competitive Strengths & Weaknesses
7.10 BlueStar Genomic
7.10.1 BlueStar Genomic Details
7.10.2 BlueStar Genomic Major Business
7.10.3 BlueStar Genomic Neurosurgery Drug Product and Services
7.10.4 BlueStar Genomic Neurosurgery Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.10.5 BlueStar Genomic Recent Developments/Updates
7.10.6 BlueStar Genomic Competitive Strengths & Weaknesses
7.11 Tonix Pharmaceuticals
7.11.1 Tonix Pharmaceuticals Details
7.11.2 Tonix Pharmaceuticals Major Business
7.11.3 Tonix Pharmaceuticals Neurosurgery Drug Product and Services
7.11.4 Tonix Pharmaceuticals Neurosurgery Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.11.5 Tonix Pharmaceuticals Recent Developments/Updates
7.11.6 Tonix Pharmaceuticals Competitive Strengths & Weaknesses
7.12 BlackThorn Therapeutics
7.12.1 BlackThorn Therapeutics Details
7.12.2 BlackThorn Therapeutics Major Business
7.12.3 BlackThorn Therapeutics Neurosurgery Drug Product and Services
7.12.4 BlackThorn Therapeutics Neurosurgery Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.12.5 BlackThorn Therapeutics Recent Developments/Updates
7.12.6 BlackThorn Therapeutics Competitive Strengths & Weaknesses
7.13 Quentrix
7.13.1 Quentrix Details
7.13.2 Quentrix Major Business
7.13.3 Quentrix Neurosurgery Drug Product and Services
7.13.4 Quentrix Neurosurgery Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.13.5 Quentrix Recent Developments/Updates
7.13.6 Quentrix Competitive Strengths & Weaknesses
7.14 Wren Pharmaceuticals
7.14.1 Wren Pharmaceuticals Details
7.14.2 Wren Pharmaceuticals Major Business
7.14.3 Wren Pharmaceuticals Neurosurgery Drug Product and Services
7.14.4 Wren Pharmaceuticals Neurosurgery Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.14.5 Wren Pharmaceuticals Recent Developments/Updates
7.14.6 Wren Pharmaceuticals Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of Neurosurgery Drug and Key Manufacturers
8.2 Neurosurgery Drug Manufacturing Costs
8.3 Neurosurgery Drug Production Process
8.4 Neurosurgery Drug Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for Neurosurgery Drug Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Neurosurgery Drug Typical Distributors
9.3 Neurosurgery Drug Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
LIST OF TABLES
Table 1. World Neurosurgery Drug Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Neurosurgery Drug Production Value by Region (2017-2022) & (USD Million)
Table 3. World Neurosurgery Drug Production Value by Region (2023-2028) & (USD Million)
Table 4. World Neurosurgery Drug Production Value Market Share by Region (2017-2022)
Table 5. World Neurosurgery Drug Production Value Market Share by Region (2023-2028)
Table 6. World Neurosurgery Drug Production by Region (2017-2022) & (K Units)
Table 7. World Neurosurgery Drug Production by Region (2023-2028) & (K Units)
Table 8. World Neurosurgery Drug Production Market Share by Region (2017-2022)
Table 9. World Neurosurgery Drug Production Market Share by Region (2023-2028)
Table 10. World Neurosurgery Drug Average Price by Region (2017-2022) & (US$/Unit)
Table 11. World Neurosurgery Drug Average Price by Region (2023-2028) & (US$/Unit)
Table 12. Neurosurgery Drug Major Market Trends
Table 13. World Neurosurgery Drug Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (K Units)
Table 14. World Neurosurgery Drug Consumption by Region (2017-2022) & (K Units)
Table 15. World Neurosurgery Drug Consumption Forecast by Region (2023-2028) & (K Units)
Table 16. World Neurosurgery Drug Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key Neurosurgery Drug Producers in 2021
Table 18. World Neurosurgery Drug Production by Manufacturer (2017-2022) & (K Units)
Table 19. Production Market Share of Key Neurosurgery Drug Producers in 2021
Table 20. World Neurosurgery Drug Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 21. Global Neurosurgery Drug Company Evaluation Quadrant
Table 22. World Neurosurgery Drug Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and Neurosurgery Drug Production Site of Key Manufacturer
Table 24. Neurosurgery Drug Market: Company Product Type Footprint
Table 25. Neurosurgery Drug Market: Company Product Application Footprint
Table 26. Neurosurgery Drug Competitive Factors
Table 27. Neurosurgery Drug New Entrant and Capacity Expansion Plans
Table 28. Neurosurgery Drug Mergers & Acquisitions Activity
Table 29. United States VS China Neurosurgery Drug Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China Neurosurgery Drug Production Comparison, (2017 & 2021 & 2028) & (K Units)
Table 31. United States VS China Neurosurgery Drug Consumption Comparison, (2017 & 2021 & 2028) & (K Units)
Table 32. Major Manufacturer of Neurosurgery Drug in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States Neurosurgery Drug Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States Neurosurgery Drug Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States Neurosurgery Drug Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 36. United States Neurosurgery Drug Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of Neurosurgery Drug in China, Company Headquarters and Production Place (Province, Country)
Table 38. China Neurosurgery Drug Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China Neurosurgery Drug Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China Neurosurgery Drug Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 41. China Neurosurgery Drug Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of Neurosurgery Drug in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World Neurosurgery Drug Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World Neurosurgery Drug Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World Neurosurgery Drug Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 46. Rest of World Neurosurgery Drug Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World Neurosurgery Drug Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World Neurosurgery Drug Production by Type (2017-2022) & (K Units)
Table 49. World Neurosurgery Drug Production by Type (2023-2028) & (K Units)
Table 50. World Neurosurgery Drug Production Value by Type (2017-2022) & (USD Million)
Table 51. World Neurosurgery Drug Production Value by Type (2023-2028) & (USD Million)
Table 52. World Neurosurgery Drug Average Price by Type (2017-2022) & (US$/Unit)
Table 53. World Neurosurgery Drug Average Price by Type (2023-2028) & (US$/Unit)
Table 54. World Neurosurgery Drug Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World Neurosurgery Drug Production by Application (2017-2022) & (K Units)
Table 56. World Neurosurgery Drug Production by Application (2023-2028) & (K Units)
Table 57. World Neurosurgery Drug Production Value by Application (2017-2022) & (USD Million)
Table 58. World Neurosurgery Drug Production Value by Application (2023-2028) & (USD Million)
Table 59. World Neurosurgery Drug Average Price by Application (2017-2022) & (US$/Unit)
Table 60. World Neurosurgery Drug Average Price by Application (2023-2028) & (US$/Unit)
Table 61. Pfizer Basic Information, Manufacturing Base and Competitors
Table 62. Pfizer Major Business
Table 63. Pfizer Neurosurgery Drug Product and Services
Table 64. Pfizer Neurosurgery Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. Pfizer Recent Developments/Updates
Table 66. Pfizer Competitive Strengths & Weaknesses
Table 67. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 68. AstraZeneca Major Business
Table 69. AstraZeneca Neurosurgery Drug Product and Services
Table 70. AstraZeneca Neurosurgery Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. AstraZeneca Recent Developments/Updates
Table 72. AstraZeneca Competitive Strengths & Weaknesses
Table 73. Biogen Basic Information, Manufacturing Base and Competitors
Table 74. Biogen Major Business
Table 75. Biogen Neurosurgery Drug Product and Services
Table 76. Biogen Neurosurgery Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. Biogen Recent Developments/Updates
Table 78. Biogen Competitive Strengths & Weaknesses
Table 79. Jhonson & Jhonson Basic Information, Manufacturing Base and Competitors
Table 80. Jhonson & Jhonson Major Business
Table 81. Jhonson & Jhonson Neurosurgery Drug Product and Services
Table 82. Jhonson & Jhonson Neurosurgery Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. Jhonson & Jhonson Recent Developments/Updates
Table 84. Jhonson & Jhonson Competitive Strengths & Weaknesses
Table 85. ABBVIE Basic Information, Manufacturing Base and Competitors
Table 86. ABBVIE Major Business
Table 87. ABBVIE Neurosurgery Drug Product and Services
Table 88. ABBVIE Neurosurgery Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. ABBVIE Recent Developments/Updates
Table 90. ABBVIE Competitive Strengths & Weaknesses
Table 91. Takeda Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 92. Takeda Pharmaceuticals Major Business
Table 93. Takeda Pharmaceuticals Neurosurgery Drug Product and Services
Table 94. Takeda Pharmaceuticals Neurosurgery Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. Takeda Pharmaceuticals Recent Developments/Updates
Table 96. Takeda Pharmaceuticals Competitive Strengths & Weaknesses
Table 97. UCB Basic Information, Manufacturing Base and Competitors
Table 98. UCB Major Business
Table 99. UCB Neurosurgery Drug Product and Services
Table 100. UCB Neurosurgery Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 101. UCB Recent Developments/Updates
Table 102. UCB Competitive Strengths & Weaknesses
Table 103. IPSEN Basic Information, Manufacturing Base and Competitors
Table 104. IPSEN Major Business
Table 105. IPSEN Neurosurgery Drug Product and Services
Table 106. IPSEN Neurosurgery Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 107. IPSEN Recent Developments/Updates
Table 108. IPSEN Competitive Strengths & Weaknesses
Table 109. Standigm Basic Information, Manufacturing Base and Competitors
Table 110. Standigm Major Business
Table 111. Standigm Neurosurgery Drug Product and Services
Table 112. Standigm Neurosurgery Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 113. Standigm Recent Developments/Updates
Table 114. Standigm Competitive Strengths & Weaknesses
Table 115. BlueStar Genomic Basic Information, Manufacturing Base and Competitors
Table 116. BlueStar Genomic Major Business
Table 117. BlueStar Genomic Neurosurgery Drug Product and Services
Table 118. BlueStar Genomic Neurosurgery Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 119. BlueStar Genomic Recent Developments/Updates
Table 120. BlueStar Genomic Competitive Strengths & Weaknesses
Table 121. Tonix Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 122. Tonix Pharmaceuticals Major Business
Table 123. Tonix Pharmaceuticals Neurosurgery Drug Product and Services
Table 124. Tonix Pharmaceuticals Neurosurgery Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 125. Tonix Pharmaceuticals Recent Developments/Updates
Table 126. Tonix Pharmaceuticals Competitive Strengths & Weaknesses
Table 127. BlackThorn Therapeutics Basic Information, Manufacturing Base and Competitors
Table 128. BlackThorn Therapeutics Major Business
Table 129. BlackThorn Therapeutics Neurosurgery Drug Product and Services
Table 130. BlackThorn Therapeutics Neurosurgery Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 131. BlackThorn Therapeutics Recent Developments/Updates
Table 132. BlackThorn Therapeutics Competitive Strengths & Weaknesses
Table 133. Quentrix Basic Information, Manufacturing Base and Competitors
Table 134. Quentrix Major Business
Table 135. Quentrix Neurosurgery Drug Product and Services
Table 136. Quentrix Neurosurgery Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 137. Quentrix Recent Developments/Updates
Table 138. Wren Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 139. Wren Pharmaceuticals Major Business
Table 140. Wren Pharmaceuticals Neurosurgery Drug Product and Services
Table 141. Wren Pharmaceuticals Neurosurgery Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 142. Neurosurgery Drug Raw Material
Table 143. Key Manufacturers of Neurosurgery Drug Raw Materials
Table 144. Neurosurgery Drug Typical Distributors
Table 145. Neurosurgery Drug Typical Customers
Table 1. World Neurosurgery Drug Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Neurosurgery Drug Production Value by Region (2017-2022) & (USD Million)
Table 3. World Neurosurgery Drug Production Value by Region (2023-2028) & (USD Million)
Table 4. World Neurosurgery Drug Production Value Market Share by Region (2017-2022)
Table 5. World Neurosurgery Drug Production Value Market Share by Region (2023-2028)
Table 6. World Neurosurgery Drug Production by Region (2017-2022) & (K Units)
Table 7. World Neurosurgery Drug Production by Region (2023-2028) & (K Units)
Table 8. World Neurosurgery Drug Production Market Share by Region (2017-2022)
Table 9. World Neurosurgery Drug Production Market Share by Region (2023-2028)
Table 10. World Neurosurgery Drug Average Price by Region (2017-2022) & (US$/Unit)
Table 11. World Neurosurgery Drug Average Price by Region (2023-2028) & (US$/Unit)
Table 12. Neurosurgery Drug Major Market Trends
Table 13. World Neurosurgery Drug Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (K Units)
Table 14. World Neurosurgery Drug Consumption by Region (2017-2022) & (K Units)
Table 15. World Neurosurgery Drug Consumption Forecast by Region (2023-2028) & (K Units)
Table 16. World Neurosurgery Drug Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key Neurosurgery Drug Producers in 2021
Table 18. World Neurosurgery Drug Production by Manufacturer (2017-2022) & (K Units)
Table 19. Production Market Share of Key Neurosurgery Drug Producers in 2021
Table 20. World Neurosurgery Drug Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 21. Global Neurosurgery Drug Company Evaluation Quadrant
Table 22. World Neurosurgery Drug Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and Neurosurgery Drug Production Site of Key Manufacturer
Table 24. Neurosurgery Drug Market: Company Product Type Footprint
Table 25. Neurosurgery Drug Market: Company Product Application Footprint
Table 26. Neurosurgery Drug Competitive Factors
Table 27. Neurosurgery Drug New Entrant and Capacity Expansion Plans
Table 28. Neurosurgery Drug Mergers & Acquisitions Activity
Table 29. United States VS China Neurosurgery Drug Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China Neurosurgery Drug Production Comparison, (2017 & 2021 & 2028) & (K Units)
Table 31. United States VS China Neurosurgery Drug Consumption Comparison, (2017 & 2021 & 2028) & (K Units)
Table 32. Major Manufacturer of Neurosurgery Drug in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States Neurosurgery Drug Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States Neurosurgery Drug Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States Neurosurgery Drug Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 36. United States Neurosurgery Drug Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of Neurosurgery Drug in China, Company Headquarters and Production Place (Province, Country)
Table 38. China Neurosurgery Drug Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China Neurosurgery Drug Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China Neurosurgery Drug Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 41. China Neurosurgery Drug Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of Neurosurgery Drug in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World Neurosurgery Drug Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World Neurosurgery Drug Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World Neurosurgery Drug Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 46. Rest of World Neurosurgery Drug Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World Neurosurgery Drug Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World Neurosurgery Drug Production by Type (2017-2022) & (K Units)
Table 49. World Neurosurgery Drug Production by Type (2023-2028) & (K Units)
Table 50. World Neurosurgery Drug Production Value by Type (2017-2022) & (USD Million)
Table 51. World Neurosurgery Drug Production Value by Type (2023-2028) & (USD Million)
Table 52. World Neurosurgery Drug Average Price by Type (2017-2022) & (US$/Unit)
Table 53. World Neurosurgery Drug Average Price by Type (2023-2028) & (US$/Unit)
Table 54. World Neurosurgery Drug Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World Neurosurgery Drug Production by Application (2017-2022) & (K Units)
Table 56. World Neurosurgery Drug Production by Application (2023-2028) & (K Units)
Table 57. World Neurosurgery Drug Production Value by Application (2017-2022) & (USD Million)
Table 58. World Neurosurgery Drug Production Value by Application (2023-2028) & (USD Million)
Table 59. World Neurosurgery Drug Average Price by Application (2017-2022) & (US$/Unit)
Table 60. World Neurosurgery Drug Average Price by Application (2023-2028) & (US$/Unit)
Table 61. Pfizer Basic Information, Manufacturing Base and Competitors
Table 62. Pfizer Major Business
Table 63. Pfizer Neurosurgery Drug Product and Services
Table 64. Pfizer Neurosurgery Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. Pfizer Recent Developments/Updates
Table 66. Pfizer Competitive Strengths & Weaknesses
Table 67. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 68. AstraZeneca Major Business
Table 69. AstraZeneca Neurosurgery Drug Product and Services
Table 70. AstraZeneca Neurosurgery Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. AstraZeneca Recent Developments/Updates
Table 72. AstraZeneca Competitive Strengths & Weaknesses
Table 73. Biogen Basic Information, Manufacturing Base and Competitors
Table 74. Biogen Major Business
Table 75. Biogen Neurosurgery Drug Product and Services
Table 76. Biogen Neurosurgery Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. Biogen Recent Developments/Updates
Table 78. Biogen Competitive Strengths & Weaknesses
Table 79. Jhonson & Jhonson Basic Information, Manufacturing Base and Competitors
Table 80. Jhonson & Jhonson Major Business
Table 81. Jhonson & Jhonson Neurosurgery Drug Product and Services
Table 82. Jhonson & Jhonson Neurosurgery Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. Jhonson & Jhonson Recent Developments/Updates
Table 84. Jhonson & Jhonson Competitive Strengths & Weaknesses
Table 85. ABBVIE Basic Information, Manufacturing Base and Competitors
Table 86. ABBVIE Major Business
Table 87. ABBVIE Neurosurgery Drug Product and Services
Table 88. ABBVIE Neurosurgery Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. ABBVIE Recent Developments/Updates
Table 90. ABBVIE Competitive Strengths & Weaknesses
Table 91. Takeda Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 92. Takeda Pharmaceuticals Major Business
Table 93. Takeda Pharmaceuticals Neurosurgery Drug Product and Services
Table 94. Takeda Pharmaceuticals Neurosurgery Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. Takeda Pharmaceuticals Recent Developments/Updates
Table 96. Takeda Pharmaceuticals Competitive Strengths & Weaknesses
Table 97. UCB Basic Information, Manufacturing Base and Competitors
Table 98. UCB Major Business
Table 99. UCB Neurosurgery Drug Product and Services
Table 100. UCB Neurosurgery Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 101. UCB Recent Developments/Updates
Table 102. UCB Competitive Strengths & Weaknesses
Table 103. IPSEN Basic Information, Manufacturing Base and Competitors
Table 104. IPSEN Major Business
Table 105. IPSEN Neurosurgery Drug Product and Services
Table 106. IPSEN Neurosurgery Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 107. IPSEN Recent Developments/Updates
Table 108. IPSEN Competitive Strengths & Weaknesses
Table 109. Standigm Basic Information, Manufacturing Base and Competitors
Table 110. Standigm Major Business
Table 111. Standigm Neurosurgery Drug Product and Services
Table 112. Standigm Neurosurgery Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 113. Standigm Recent Developments/Updates
Table 114. Standigm Competitive Strengths & Weaknesses
Table 115. BlueStar Genomic Basic Information, Manufacturing Base and Competitors
Table 116. BlueStar Genomic Major Business
Table 117. BlueStar Genomic Neurosurgery Drug Product and Services
Table 118. BlueStar Genomic Neurosurgery Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 119. BlueStar Genomic Recent Developments/Updates
Table 120. BlueStar Genomic Competitive Strengths & Weaknesses
Table 121. Tonix Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 122. Tonix Pharmaceuticals Major Business
Table 123. Tonix Pharmaceuticals Neurosurgery Drug Product and Services
Table 124. Tonix Pharmaceuticals Neurosurgery Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 125. Tonix Pharmaceuticals Recent Developments/Updates
Table 126. Tonix Pharmaceuticals Competitive Strengths & Weaknesses
Table 127. BlackThorn Therapeutics Basic Information, Manufacturing Base and Competitors
Table 128. BlackThorn Therapeutics Major Business
Table 129. BlackThorn Therapeutics Neurosurgery Drug Product and Services
Table 130. BlackThorn Therapeutics Neurosurgery Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 131. BlackThorn Therapeutics Recent Developments/Updates
Table 132. BlackThorn Therapeutics Competitive Strengths & Weaknesses
Table 133. Quentrix Basic Information, Manufacturing Base and Competitors
Table 134. Quentrix Major Business
Table 135. Quentrix Neurosurgery Drug Product and Services
Table 136. Quentrix Neurosurgery Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 137. Quentrix Recent Developments/Updates
Table 138. Wren Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 139. Wren Pharmaceuticals Major Business
Table 140. Wren Pharmaceuticals Neurosurgery Drug Product and Services
Table 141. Wren Pharmaceuticals Neurosurgery Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 142. Neurosurgery Drug Raw Material
Table 143. Key Manufacturers of Neurosurgery Drug Raw Materials
Table 144. Neurosurgery Drug Typical Distributors
Table 145. Neurosurgery Drug Typical Customers
LIST OF FIGURES
Figure 1. Neurosurgery Drug Picture
Figure 2. World Neurosurgery Drug Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Neurosurgery Drug Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World Neurosurgery Drug Production (2017-2028) & (K Units)
Figure 5. World Neurosurgery Drug Average Price (2017-2028) & (US$/Unit)
Figure 6. World Neurosurgery Drug Production Value Market Share by Region (2017-2028)
Figure 7. World Neurosurgery Drug Production Market Share by Region (2017-2028)
Figure 8. North America Neurosurgery Drug Production (2017-2028) & (K Units)
Figure 9. Europe Neurosurgery Drug Production (2017-2028) & (K Units)
Figure 10. China Neurosurgery Drug Production (2017-2028) & (K Units)
Figure 11. Japan Neurosurgery Drug Production (2017-2028) & (K Units)
Figure 12. Neurosurgery Drug Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Neurosurgery Drug Demand (2017-2028) & (K Units)
Figure 15. World Neurosurgery Drug Consumption Market Share by Region (2017-2028)
Figure 16. United States Neurosurgery Drug Consumption (2017-2028) & (K Units)
Figure 17. China Neurosurgery Drug Consumption (2017-2028) & (K Units)
Figure 18. Europe Neurosurgery Drug Consumption (2017-2028) & (K Units)
Figure 19. Japan Neurosurgery Drug Consumption (2017-2028) & (K Units)
Figure 20. South Korea Neurosurgery Drug Consumption (2017-2028) & (K Units)
Figure 21. ASEAN Neurosurgery Drug Consumption (2017-2028) & (K Units)
Figure 22. India Neurosurgery Drug Consumption (2017-2028) & (K Units)
Figure 23. Producer Shipments of Neurosurgery Drug by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for Neurosurgery Drug Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for Neurosurgery Drug Markets in 2021
Figure 26. United States VS China: Neurosurgery Drug Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: Neurosurgery Drug Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: Neurosurgery Drug Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of Neurosurgery Drug in United States
Figure 30. Key Producers and Market Share of Neurosurgery Drug in China
Figure 31. Key Producers and Market Share of Neurosurgery Drug in Rest of World
Figure 32. World Neurosurgery Drug Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World Neurosurgery Drug Production Value Market Share by Type in 2021
Figure 34. Tablets
Figure 35. Solution
Figure 36. Capsules
Figure 37. Others
Figure 38. World Neurosurgery Drug Production Market Share by Type (2017-2028)
Figure 39. World Neurosurgery Drug Production Value Market Share by Type (2017-2028)
Figure 40. World Neurosurgery Drug Average Price by Type (2017-2028) & (US$/Unit)
Figure 41. World Neurosurgery Drug Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 42. World Neurosurgery Drug Production Value Market Share by Application in 2021
Figure 43. Hospital
Figure 44. Clinic
Figure 45. Others
Figure 46. World Neurosurgery Drug Production Market Share by Application (2017-2028)
Figure 47. World Neurosurgery Drug Production Value Market Share by Application (2017-2028)
Figure 48. World Neurosurgery Drug Average Price by Application (2017-2028) & (US$/Unit)
Figure 49. Manufacturing Cost Structure Analysis of Neurosurgery Drug in 2021
Figure 50. Manufacturing Process Analysis of Neurosurgery Drug
Figure 51. Neurosurgery Drug Industrial Chain
Figure 52. Distribution Channel Breakdown for Neurosurgery Drug Shipments (%): 2017-2028
Figure 53. Direct Channel Pros & Cons
Figure 54. Indirect Channel Pros & Cons
Figure 55. Methodology
Figure 56. Research Process and Data Source
Figure 1. Neurosurgery Drug Picture
Figure 2. World Neurosurgery Drug Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Neurosurgery Drug Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World Neurosurgery Drug Production (2017-2028) & (K Units)
Figure 5. World Neurosurgery Drug Average Price (2017-2028) & (US$/Unit)
Figure 6. World Neurosurgery Drug Production Value Market Share by Region (2017-2028)
Figure 7. World Neurosurgery Drug Production Market Share by Region (2017-2028)
Figure 8. North America Neurosurgery Drug Production (2017-2028) & (K Units)
Figure 9. Europe Neurosurgery Drug Production (2017-2028) & (K Units)
Figure 10. China Neurosurgery Drug Production (2017-2028) & (K Units)
Figure 11. Japan Neurosurgery Drug Production (2017-2028) & (K Units)
Figure 12. Neurosurgery Drug Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Neurosurgery Drug Demand (2017-2028) & (K Units)
Figure 15. World Neurosurgery Drug Consumption Market Share by Region (2017-2028)
Figure 16. United States Neurosurgery Drug Consumption (2017-2028) & (K Units)
Figure 17. China Neurosurgery Drug Consumption (2017-2028) & (K Units)
Figure 18. Europe Neurosurgery Drug Consumption (2017-2028) & (K Units)
Figure 19. Japan Neurosurgery Drug Consumption (2017-2028) & (K Units)
Figure 20. South Korea Neurosurgery Drug Consumption (2017-2028) & (K Units)
Figure 21. ASEAN Neurosurgery Drug Consumption (2017-2028) & (K Units)
Figure 22. India Neurosurgery Drug Consumption (2017-2028) & (K Units)
Figure 23. Producer Shipments of Neurosurgery Drug by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for Neurosurgery Drug Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for Neurosurgery Drug Markets in 2021
Figure 26. United States VS China: Neurosurgery Drug Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: Neurosurgery Drug Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: Neurosurgery Drug Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of Neurosurgery Drug in United States
Figure 30. Key Producers and Market Share of Neurosurgery Drug in China
Figure 31. Key Producers and Market Share of Neurosurgery Drug in Rest of World
Figure 32. World Neurosurgery Drug Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World Neurosurgery Drug Production Value Market Share by Type in 2021
Figure 34. Tablets
Figure 35. Solution
Figure 36. Capsules
Figure 37. Others
Figure 38. World Neurosurgery Drug Production Market Share by Type (2017-2028)
Figure 39. World Neurosurgery Drug Production Value Market Share by Type (2017-2028)
Figure 40. World Neurosurgery Drug Average Price by Type (2017-2028) & (US$/Unit)
Figure 41. World Neurosurgery Drug Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 42. World Neurosurgery Drug Production Value Market Share by Application in 2021
Figure 43. Hospital
Figure 44. Clinic
Figure 45. Others
Figure 46. World Neurosurgery Drug Production Market Share by Application (2017-2028)
Figure 47. World Neurosurgery Drug Production Value Market Share by Application (2017-2028)
Figure 48. World Neurosurgery Drug Average Price by Application (2017-2028) & (US$/Unit)
Figure 49. Manufacturing Cost Structure Analysis of Neurosurgery Drug in 2021
Figure 50. Manufacturing Process Analysis of Neurosurgery Drug
Figure 51. Neurosurgery Drug Industrial Chain
Figure 52. Distribution Channel Breakdown for Neurosurgery Drug Shipments (%): 2017-2028
Figure 53. Direct Channel Pros & Cons
Figure 54. Indirect Channel Pros & Cons
Figure 55. Methodology
Figure 56. Research Process and Data Source
